Home / Services / Thyroid Optimization

Hormone and Metabolic Health

Thyroid Optimization

Thyroid optimization is the clinical process of restoring tissue level thyroid hormone activity, not simply normalizing a single pituitary marker. Thyroid function depends on three separate steps: gland output, peripheral conversion of T4 into active T3, and receptor level response inside the cell. A TSH only workup evaluates the first step and infers the other two, which is why patients with normal TSH routinely remain fatigued, cold, cognitively slowed, and unable to lose weight. Functional medicine measures each step directly and identifies which one is failing. At The Lamkin Clinic, Brian Lamkin, DO evaluates the complete thyroid cascade alongside the nutrient, adrenal, and inflammatory inputs that govern conversion, then builds a treatment plan around the specific mechanism identified.

Physician Led Functional Medicine Edmond, Oklahoma

6 Markers in a complete thyroid panel

2.5 TSH mIU/L where we investigate further

25+ Years of clinical practice

Schedule a Consultation

← Back to Services

Category: Hormone and Metabolic Health Systems: Endocrine, Metabolic, Neurologic Focus: Conversion Assessment, Autoimmune Screening, Optimization

Most thyroid treatment failures are not dosing failures. They are measurement failures. When a patient is titrated on TSH alone, an impaired T4 to T3 conversion or an active autoimmune process can persist for years while the lab report reads normal and the symptoms never resolve.

What Thyroid Optimization Addresses

Thyroid optimization at The Lamkin Clinic is a structured clinical service for patients whose thyroid physiology has not been fully evaluated. It addresses three distinct problems that a standard screening panel cannot distinguish between: insufficient hormone production by the gland itself, impaired peripheral conversion of the storage hormone T4 into the active hormone T3, and autoimmune destruction of thyroid tissue that begins long before any hormone value moves out of range. Each of these produces a nearly identical symptom picture. Each requires a different intervention. Treating all three as if they were the same condition is the central reason so many thyroid patients remain symptomatic on therapy.

The service is not limited to patients with a formal diagnosis. A substantial portion of the patients we evaluate arrive with a completed workup, a documented normal TSH result, and no explanation for persistent fatigue, cold intolerance, weight gain resistance, hair thinning, constipation, or cognitive slowing. In these patients the thyroid gland is frequently producing adequate hormone while the conversion step downstream is failing, a state that a pituitary marker is structurally incapable of detecting.

Patients Already on Thyroid Medication

Levothyroxine supplies T4 only. It assumes the body will convert that T4 into active T3 efficiently. When conversion is impaired by low ferritin, low selenium, elevated cortisol, or inflammatory burden, adding T4 supplies more substrate to a blocked pathway and can raise Reverse T3 further. The patient reports that each dose increase normalized the lab value without improving how they feel. We evaluate whether the problem is dose, formulation, conversion capacity, or absorption before adjusting anything.

Patients Told Their Thyroid Is Normal

A normal TSH excludes overt primary gland failure. It does not exclude low tissue thyroid activity. Patients in this group typically have a TSH between 2.0 and 4.5 mIU/L with a Free T3 level in the bottom quartile of the reference range, or positive thyroid antibodies with hormone values that are still fully compensated. Both patterns are clinically meaningful and both are routinely reported as normal because no marker crossed a reference boundary.

Our Approach to Thyroid Optimization

Our approach begins from a specific premise: the thyroid does not operate as an isolated organ. Thyroid hormone output is regulated by the pituitary, activated by deiodinase enzymes in the liver, gut, and peripheral tissue, transported by binding proteins that respond to estrogen and insulin status, and modulated at the receptor by cortisol and inflammatory signaling. A treatment plan that addresses only gland output ignores four of the five points where the system can fail.

We therefore evaluate the entire cascade before treating any part of it. That means measuring the active hormone rather than inferring it, measuring the inactive isomer that competes for receptor binding, screening for autoimmunity in every patient rather than only in those with abnormal hormone values, and assessing the nutrient and adrenal inputs that determine whether conversion can proceed at all. Only after the failing step is identified does treatment begin, and the treatment is selected to correct that specific step.

The reference range question deserves direct comment, because it is where conventional and functional interpretation diverge most sharply. Laboratory reference intervals are constructed from population distributions, which means they describe where most people fall rather than where people function well. Those populations include a substantial number of individuals with undiagnosed thyroid disease and unrecognized nutrient deficiency, which widens the interval and pulls the lower boundary down. A Free T3 result in the bottom decile of the range is reported as normal and is nonetheless associated with hypothyroid symptoms in routine clinical practice. Functional optimal targets are narrower and are derived from symptom correlation and outcomes rather than from the shape of a distribution curve. This is why a patient can be told repeatedly that every value is normal while every value sits in the region where function is measurably impaired.

Conventional Thyroid Care	Thyroid Optimization at The Lamkin Clinic
Screens with TSH, adds Free T4 only if TSH is abnormal	Measures the full cascade at baseline including TSH, Free T4, Free T3, Reverse T3, and both antibody markers
Treats when TSH exceeds the laboratory upper limit, commonly 4.5 mIU/L, and often waits until 10 mIU/L	Investigates further when TSH exceeds 2.5 mIU/L in a symptomatic patient, particularly with low Free T3 or positive antibodies
Prescribes T4 monotherapy and titrates to a normal TSH	Selects therapy based on the identified mechanism, which may include conversion support, nutrient repletion, autoimmune modulation, or combination hormone therapy
Considers the case resolved when TSH normalizes, regardless of residual symptoms	Considers the case resolved when Free T3, symptoms, resting metabolic markers, and antibody trend all align
Screens for autoimmunity only after hormone values become abnormal	Screens both TPO and thyroglobulin antibodies at baseline, since autoimmune activity precedes hormone change by years

The Thyroid Optimization Process

The process is sequential by design. Each step produces the information required to make the next decision correctly, which is what prevents the trial and error dose adjustment cycle that characterizes so much thyroid care.

01 Clinical Intake

A full symptom timeline, medication and supplement history, prior lab records, family autoimmune history, and dietary and stress exposure. Prior results matter because the trajectory of a marker over time is often more informative than any single value.

02 Complete Panel

Baseline testing of the full thyroid cascade plus the conversion cofactors and inflammatory markers that govern it. Drawing these together rather than sequentially allows the pattern to be read as a whole.

03 Mechanism Identification

Results are interpreted as a pattern, not as isolated values. The objective is to name which of the three failure points is operating: production, conversion, or autoimmunity. Some patients have two operating simultaneously.

04 Root Cause Correction

Nutrient deficiencies are repleted, adrenal and inflammatory drivers of conversion impairment are addressed, and autoimmune triggers are investigated before or alongside hormone therapy rather than after it.

05 Hormone Therapy

Where hormone replacement is indicated, the formulation is matched to the mechanism. Conversion impairment is not corrected by more T4. Dosing targets tissue level markers and symptom resolution, not a single pituitary value.

06 Retest and Adjust

Repeat panels at defined intervals confirm whether the intervention moved the marker it was intended to move. Antibody trend is tracked over time in autoimmune patients as a measure of whether the immune driver is being controlled.

Who Is a Candidate for Thyroid Optimization

This service is appropriate for patients whose clinical picture and laboratory picture do not agree, and for patients whose treatment has plateaued short of full symptom resolution. The following presentations are the ones we see most consistently.

You have hypothyroid symptoms and were told your thyroid is normal on the basis of a TSH result alone, with no Free T3, Reverse T3, or antibody testing performed.
You take levothyroxine, your TSH is in range, and you remain fatigued, cold, cognitively slowed, or unable to lose weight. This is the single most common presentation in our thyroid practice.
You have confirmed Hashimoto's thyroiditis and have been offered hormone replacement but no evaluation of the autoimmune drivers behind it.
Your TSH sits between 2.5 and 4.5 mIU/L, which meets the functional threshold for further investigation but not the conventional threshold for treatment. This pattern is covered in depth on our subclinical hypothyroidism page.
You have a family history of autoimmune thyroid disease and want baseline antibody screening before symptoms or hormone changes appear.
You are being evaluated for chronic fatigue, brain fog, or weight loss resistance and thyroid function has not been fully excluded as a contributor.
You have overactive thyroid symptoms including palpitations, heat intolerance, tremor, or unintended weight loss. These require prompt evaluation and are addressed on our hyperthyroidism page.

Thyroid dysfunction rarely presents alone. Because the same upstream drivers that impair thyroid conversion also disrupt adrenal and reproductive hormone signaling, evaluation frequently overlaps with HPA axis dysfunction and broader hormone imbalance. The overlap is mechanistic rather than coincidental. Sustained cortisol elevation both suppresses pituitary TSH output and accelerates the shunting of T4 toward its inactive isomer, so a stressed patient can present with a deceptively low TSH and genuinely low tissue thyroid activity at the same time. Estrogen raises thyroxine binding globulin, which lowers the free hormone fraction available to tissue even when total hormone production is unchanged, a pattern that surfaces during perimenopause and with oral estrogen therapy. Insulin resistance and chronic inflammation independently suppress deiodinase activity. Where any of these are present, thyroid optimization is coordinated with the relevant evaluation rather than run in isolation, because correcting the thyroid axis while leaving its upstream regulator uncorrected produces a temporary result at best.

Diagnostics Used in Thyroid Optimization

The panel below is the baseline for every thyroid optimization patient. Each marker answers a question the others cannot answer, which is why partial panels produce incomplete conclusions. Every marker links to its full reference page with standard ranges, functional optimal ranges, and interpretation guidance.

TSH Free T4 Free T3 Reverse T3 TPO Antibodies Thyroglobulin Antibodies

These six markers separate the three failure points. A high TSH with low Free T4 indicates gland level production failure. A normal TSH and normal Free T4 with low Free T3 indicates a conversion problem, not a production problem. Elevated Reverse T3 alongside low Free T3 indicates that T4 is being actively shunted down the inactivation pathway, which happens under cortisol elevation, inflammatory burden, iron deficiency, and caloric restriction. Positive antibodies establish an autoimmune process regardless of what the hormone values show.

Both antibody markers are drawn, not just TPO. Roughly a third of Hashimoto's cases are thyroglobulin antibody positive with negative TPO antibodies, which means a TPO only screen returns a false reassurance in a meaningful share of autoimmune patients.

Conversion cofactors are drawn alongside the thyroid panel because a conversion deficit cannot be corrected until its cause is known. Selenium is the required cofactor for the deiodinase enzymes that activate T4, and it also lowers antibody titers in autoimmune patients. Ferritin below 50 ng/mL impairs thyroid peroxidase enzyme function directly, which is why iron status is assessed with serum iron alongside it. Zinc is required for both hormone synthesis and conversion. Vitamin D governs the immune regulation that determines autoimmune activity. Cortisol is the most potent single driver of T4 to Reverse T3 shunting, and hs-CRP quantifies the inflammatory burden that produces the same effect. Iodine status is assessed before any iodine containing supplement is considered, since excess iodine can worsen autoimmune thyroid disease.

Recommended Panel

The Hormone Optimization Panel covers the complete thyroid cascade alongside the adrenal and sex hormone markers that regulate thyroid binding, conversion, and receptor sensitivity. It is the appropriate starting panel for most thyroid optimization patients because it captures the upstream regulators rather than the thyroid axis in isolation. Results are reviewed by the physician before any treatment decision is made.

Order Hormone Optimization Panel

Where cortisol driven conversion impairment is the leading suspicion, the Adrenal and Stress panel is added or substituted. Every result is interpreted by Brian Lamkin, DO in the context of your full history and symptom picture, and the treatment plan is built from that interpretation rather than from the report itself.

Explore All Testing Options

Frequently Asked Questions About Thyroid Optimization

My TSH is normal. Why would I need thyroid optimization?

TSH is a pituitary hormone. It reports how strongly the pituitary is signaling the thyroid, not how much active hormone is reaching your cells. A patient can have a completely normal TSH while Free T3 sits at the bottom of the reference range because peripheral conversion is impaired. That patient has low tissue thyroid activity and a normal screening test at the same time. Measuring Free T3 and Reverse T3 is the only way to distinguish the two situations.

I am already on levothyroxine and my labs are in range, but I still feel terrible. What would change?

This is the most common reason patients come to us for thyroid care. Levothyroxine supplies T4 only, so it corrects a production deficit but does nothing for a conversion deficit. If your Free T3 is low and your Reverse T3 is elevated while on therapy, the problem is that the T4 you are taking is being routed toward the inactive pathway. Raising the dose in that setting supplies more substrate to the same blocked route. The correction is to address the conversion blockers, which typically means iron, selenium, cortisol, and inflammatory burden, and in some cases to change the formulation rather than the dose.

Can Hashimoto's antibodies actually be lowered, or is the diagnosis permanent?

The autoimmune predisposition does not disappear, but antibody titers are not fixed and frequently fall substantially when the drivers are addressed. Selenium repletion has the strongest evidence base for lowering TPO antibodies. Vitamin D optimization, a structured gluten elimination trial, intestinal barrier repair, and cortisol reduction all contribute. We track antibody trend across repeat panels because a falling titer indicates the immune driver is responding, which is information that a hormone value alone does not provide.

How long before I notice a difference?

Timeline depends on which mechanism is operating. Nutrient driven conversion problems often improve within six to twelve weeks of adequate repletion, though ferritin restoration specifically is slower and is rechecked at eight to twelve weeks. Hormone therapy adjustments are typically assessed at six weeks, since that is the interval required for levels to stabilize. Autoimmune modulation is measured over months rather than weeks, and antibody trend is the marker we follow. We set retest intervals at the start so expectations are defined rather than open ended.

Do you take insurance for thyroid optimization?

The Lamkin Clinic is a cash based practice and does not bill insurance. This is a deliberate structural choice. It allows appointment lengths and panel composition to be determined by clinical need rather than by coverage criteria, which is what makes a complete thyroid cascade panel and a full mechanism workup possible in the first place. Many patients submit lab work through their own insurance separately, and testing ordered through our lab partner can be purchased directly at transparent pricing.

Clinical Perspective

The pattern I see most often is a patient who has been on thyroid medication for years, whose TSH has been dutifully normalized, and who has been told there is nothing further to do. When we run the full cascade, the Free T3 is at the very bottom of the range and the Reverse T3 is elevated. Nobody ever measured either one, so nobody knew the T4 they were prescribing was being inactivated as fast as it was absorbed. The second pattern is the patient with clear symptoms, a TSH of 3.1, and positive TPO antibodies that were never drawn because the TSH looked acceptable. In both cases the information required to help the patient was one panel away, and it was never ordered.

- Brian Lamkin, DO

How The Lamkin Clinic Approaches Thyroid Optimization

Mechanism First, Then Treatment

Every thyroid patient at the clinic receives the complete cascade panel at baseline, including both antibody markers, regardless of how their TSH reads. Conversion cofactors and inflammatory markers are drawn in the same sitting so that the pattern can be interpreted as a system rather than assembled across months of sequential testing. Treatment is not initiated until the failing step has been named, because production failure, conversion failure, and autoimmune destruction require different interventions and treating the wrong one produces the plateau that brings most patients here. Where hormone therapy is indicated, dosing is titrated against Free T3, symptom resolution, and clinical signs rather than against TSH alone. Retest intervals are defined at the outset, and antibody trend is tracked over time in autoimmune patients as the measure of whether the underlying immune driver is actually being controlled. Brian Lamkin, DO reviews every panel personally and builds the plan directly with the patient.

Related Conditions

Hashimoto's Thyroiditis Autoimmune Thyroid → Subclinical Hypothyroidism Thyroid → Thyroid Dysfunction Thyroid → Hyperthyroidism Thyroid → HPA Axis Dysfunction Hormones → Chronic Fatigue Neurologic →

Related Services

Hormone Replacement Therapy Hormone and Metabolic → Medical Weight Loss Hormone and Metabolic → Cognitive Health Optimization Specialty Care → Specialty Lab Services Diagnostics and Testing →

Reviewed and approved by Brian Lamkin, DO, founder of The Lamkin Clinic with 25+ years of clinical experience in functional and regenerative medicine. This page is intended for educational purposes and does not constitute medical advice.

Ready to Get to the Root Cause?

At The Lamkin Clinic, we evaluate the complete thyroid cascade and the nutrient, adrenal, and inflammatory inputs that govern it, then build treatment around the mechanism we identify. Our patients receive a complete clinical picture, not just a diagnosis.

Schedule a Consultation

The information on this page is provided for educational purposes only and is not intended as medical advice. It does not replace a clinical evaluation, diagnosis, or personalized treatment plan from a licensed physician. Consult your healthcare provider before making any changes to your health regimen. The Lamkin Clinic is a cash-based functional and regenerative medicine practice located in Edmond, Oklahoma.